<div id="readability-page-1"><p>Cathie Wood's ARK Invest ETFs (exchange-traded funds) released their daily trade disclosures for Thursday, January 22, 2026, showing a mix of selling in biotech and software names and continued buying in AI and autonomous driving stocks.</p><h3>Claim 50% Off TipRanks Premium</h3><ul><li>Unlock  hedge fund-level data  and  powerful investing tools  for smarter, sharper decisions  </li><li> Stay ahead of the market with  the latest news and analysis  and maximize your portfolio's potential</li></ul> <h2><strong>Which Stocks Did Wood Sell on January 22?</strong></h2> <p>The largest move of the day came on the sell side. ARK reduced its position in <strong>Beam Therapeutics</strong> (BEAM), offloading 161,683 shares across the ARK Innovation ETF (ARKK) and the ARK Genomic Revolution ETF (ARKG). The sale was valued at roughly $5.03 million, making it ARK's biggest transaction of the session.</p> <p>This followed earlier Beam sales during the week, suggesting ARK is gradually trimming exposure rather than exiting the stock outright.</p> <p>ARK also continued to scale back several software and media holdings. The firm sold 32,227 shares of <strong>Unity Software</strong> (U) through the ARK Next Generation Internet ETF (ARKW) for about $1.35 million. In addition, ARK sold 14,885 shares of <strong>Roku</strong> (ROKU) for $1.55 million.</p> <p>ARK also reduced its position in <strong>GitLab</strong> (GTLB), selling 29,533 shares worth about $979,000, extending a recent pattern of trimming exposure to the software name. In smaller moves, ARK sold 2,631 shares of <strong>Kratos Defense &amp; Security Solutions </strong>(KTOS) across three ETFs for about $317,000.</p> <p>Here's how the trimmed stocks have been performing lately.</p></div>

<p>Cathie Wood's ARK Invest ETFs disclosed trades for January 22, 2026, revealing significant selling in biotech and software stocks, while continuing to invest in AI and autonomous driving. The largest transaction was the sale of 161,683 shares of Beam Therapeutics, valued at approximately $5.03 million. ARK also sold shares of Unity Software, Roku, and GitLab, indicating a strategy of gradually reducing exposure in these sectors.</p>

Tip Ranks

Proshares Ultra Nasdaq Biotech

iShares US Healthcare Providers

iShares Biotechnology ETF

Invesco Nasdaq Biotechnology ETF

Unity Software

SPDR S&P Biotech

Invesco Biotechnology & Genome ETF

Beam Therapeutics

SPDR S&P Software

iShares Genomics Immunology and Healthcare ETF

Tempus AI

VanEck Biotech ETF

ALPS Medical Breakthrough

GitLab

WeRide

Ark Genomic Revolution ETF

Roku

Ark Innovation ETF

First Trust NYSE Arca Biotech Index Fd

Health Care Select Sector SPDR

iShares Expanded Tech Software Sector ETF

Cathie Wood Dumps Over $5M in a Biotech Stock, Buys WeRide and Tempus AI